Print Page  Close Window     


Information Request


Primary IR Contact

For members of the press or investor community who wish to obtain more information about Vanda, please contact
Jim Kelly
Executive Vice President and Chief Financial Officer
Vanda Pharmaceuticals, Inc.
(202) 734-3428

To request information, please fill out and submit the form below:
Personal Information
Required fields denoted by an asterisk (
*).
First Name*Last Name*
TitleOrganization
Investor Type
Address 1Address 2
CityState / Province
Zip Code / Zone
Country
PhoneFax
E-mail*
Questions / Comments